<?xml version="1.0" encoding="UTF-8"?>
<p>On the one hand, 
 <italic>N</italic>-alkyl-DNJ derivatives could be partially protonated at physiological pH, thus mimicking the ammonium cation of acetylcholine, and enabling favourable interactions within the CAS. Although it has been reported that the presence of aromatic substituents connected to iminosugars through a short alkyl tether (2–3 carbon atoms) leads to p
 <italic>K</italic>a of 6.0
 <xref rid="CIT0037" ref-type="bibr">
  <sup>37</sup>
 </xref> or below 6.0
 <xref rid="CIT0038" ref-type="bibr">
  <sup>38</sup>
 </xref>, because of the electron-withdrawing effect of the aryl moiety, compounds prepared herein, with longer alkyl fragments are expected to tentatively exhibit higher p
 <italic>K</italic>a values, probably in between for those reported for 
 <italic>N</italic>-nonyl-DNJ and 
 <italic>N</italic>-butyl-DNJ (6.7 and 7.1, respectively)
 <xref rid="CIT0039" ref-type="bibr">
  <sup>39</sup>
 </xref>. On the other hand, as aforementioned, 1-DNJ has positive effects against amyloidogenesis. Moreover, 1-DNJ has recently been found
 <xref rid="CIT0040" ref-type="bibr">
  <sup>40</sup>
 </xref> to ameliorate stable angina pectoris in patients with coronary heart disease by reducing inflammatory responses and by increasing the antioxidant machinery. Taking into consideration that profound oxidative stress and neuroinflammation are common features of Alzheimer’s disease
 <xref rid="CIT0041" ref-type="bibr">
  <sup>41</sup>
 </xref>, the use of 1-DNJ as the pharmacophore might also provide activity against other targets of this multifactorial disease. Furthermore, different substitution patterns on the aromatic appendage might modulate the interactions within the PAS region.
</p>
